From what I gathered from the Webinar that the hard shell is ready for Dr to prescribe, at the same time ready for clinical trials but overall it was very positive as the door is left open for commercial growing when the market calls for it as its a lot cheaper to import from Chile if and when the get export license but will get it locally for now but with a boat load of cash in the bank and some big partners this company will have a bright future as the market will only keep getting bigger and bigger
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Investor Webinar
Ann: AusCann Investor Webinar, page-87
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online